Unlocking value for the patient in the consumer genomics market – a conversation with Robin Thurston

  • Mar 5, 2019

Unlocking value for the patient in the consumer genomics market – a conversation with Robin Thurston

 
 
00:00 /
 
1X

Today’s Guest: Robin Thurston | CEO of Helix

Greg and Robin break down the differences between genotyping and next-gen sequencing, how we move beyond genealogy-only use cases, and why that distinction is so important for impacting value for patients and consumers.

Important links:

Helix Web Site: http://helix.com
Helix’ DNA Product Studio: https://www.prnewswire.com/news-releases/helix-announces-dna-product-studio-to-power-rapid-development-of-new-genomics-apps-and-tests-300733874.html
Robin’s LinkedIn: https://www.linkedin.com/in/robinthurston/
Robin on Twitter: https://twitter.com/RobinJThurston

For more info about Greg Matthews, visit: http://linkedin.com/in/gdmatthews

 

 

Find Us Online

Greg Matthews

Greg Matthews

Healthcare + Data & Analytics + Strategy | Matthews has been at the forefront of healthcare innovation for the last decade, and has worked for and with some of the largest healthcare companies in the world. He is currently a healthcare data & analytics consultant based in Austin, Texas.

Sponsors